Shengmai-san-Mediated Enhancement of Regenerative Responses of Spinal Cord Axons After Injury in Rats

被引:13
作者
Seo, Tae Beom [1 ]
Baek, Kyungmin [1 ]
Kwon, Ku-Birm [1 ]
Lee, Sang-Ik [1 ]
Lim, Jong-Soon [1 ]
Seol, In Chan [1 ]
Kim, Yoon Sik [1 ]
Seo, Young-Bae [1 ]
Namgung, Uk [1 ]
机构
[1] Daejeon Univ, Dept Oriental Med, Taejon 300716, South Korea
关键词
Shengmai-san; spinal cord injury; axonal regeneration; Erk1/2; cell division cycle 2 (Cdc2); CHINESE HERBAL MEDICINE; OXIDATIVE DAMAGE; MESSENGER-RNA; VITAMIN-E; GROWTH; NERVE; EXPRESSION; NEURONS; CELLS; DEGENERATION;
D O I
10.1254/jphs.09044FP
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Shengmai-san (SMS) is a traditional Chinese medicine used to treat diverse symptoms including cardiovascular and neurological disorders. Here we investigated the effects of SMS on regenerative responses of spinal cord axons in rats that were given contusion injury at the lower thoracic level. The injury cavity was confined to a restricted area by SMS treatment, and the signals of glial scar protein chondroitin sulphate proteoglycan (CSPG) and inflammatory cell marker protein CD11 beta were heavily observed within the injury cavity in SMS-treated animals. Anterograde tracing of DiI-labeled corticospinal tract (CST) axons revealed increases in collateral arborization around and within the injury cavity and caudal elongation by SMS treatment. Furthermore, SMS treatment facilitated neurite elongation of dorsal root ganglion (DRG) sensory neurons that were co-cultured with non-neuronal cells prepared from injured spinal cord. Phospho-Erk1/2 was strongly induced in both spinal cord and motor cortical areas after spinal cord injury (SCI), and it was further unregulated in the motor cortex by SMS treatment. In contrast, upregulation of cell division cycle 2 (Cdc2) production by SMS treatment was limited to a local, SCI area. These data suggest that SMS may play an active role in regenerative responses and facilitate axonal regrowth after SCI.
引用
收藏
页码:483 / 492
页数:10
相关论文
共 47 条
[1]   OVEREXPRESSION OF THE NEURAL GROWTH-ASSOCIATED PROTEIN GAP-43 INDUCES NERVE SPROUTING IN THE ADULT NERVOUS-SYSTEM OF TRANSGENIC MICE [J].
AIGNER, L ;
ARBER, S ;
KAPFHAMMER, JP ;
LAUX, T ;
SCHNEIDER, C ;
BOTTERI, F ;
BRENNER, HR ;
CARONI, P .
CELL, 1995, 83 (02) :269-278
[2]  
Ao Q, 2006, SPINAL CORD, V44, P662, DOI 10.1038/sj.sc.3101900
[3]   Vitamin E intake and risk of amyotrophic lateral sclerosis [J].
Ascherio, A ;
Weisskopf, MG ;
O'Reilly, EJ ;
Jacobs, EJ ;
McCullough, ML ;
Calle, EE ;
Cudkowicz, M ;
Thun, MJ .
ANNALS OF NEUROLOGY, 2005, 57 (01) :104-110
[4]   Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons [J].
Bomze, HM ;
Bulsara, KR ;
Iskandar, BJ ;
Caroni, P ;
Skene, JHP .
NATURE NEUROSCIENCE, 2001, 4 (01) :38-43
[5]   Oxidative stress and ischemic injuries in heat stroke [J].
Chang, Chen-Kuei ;
Chang, Ching-Ping ;
Liu, Shyun-Yeu ;
Lin, Mao-Tsun .
NEUROBIOLOGY OF HYPERTHERMIA, 2007, 162 :525-546
[6]   RETRACTED: Shengmai (a traditional Chinese herbal medicine) for heart failure (Retracted Article) [J].
Chen, J. ;
Wu, G. ;
Li, S. ;
Yu, T. ;
Xie, Y. ;
Zhou, L. ;
Wang, L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[7]   Antioxidative therapy in contusion spinal cord injury [J].
Cristante, A. F. ;
Barros Filho, T. E. P. ;
Oliveira, R. P. ;
Marcon, R. M. ;
Rocha, I. D. ;
Hanania, F. R. ;
Daci, K. .
SPINAL CORD, 2009, 47 (06) :458-463
[8]   Fas engagement induces neurite growth through ERK activation and p35 upregulation [J].
Desbarats, J ;
Birge, RB ;
Mimouni-Rongy, M ;
Weinstein, DE ;
Palerme, JS ;
Newell, MK .
NATURE CELL BIOLOGY, 2003, 5 (02) :118-125
[9]   α-Tocopherol decreases tumor necrosis factor-α mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase [J].
Devaraj, S ;
Jialal, I .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (09) :1212-1220
[10]   Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis [J].
Di Matteo, Vincenzo ;
Esposito, Ennio .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (02) :95-107